148.12
-1.88
(-1.25%)
At close: April 8 at 11:42:04 AM CST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 21 | 21 | 23 | 22 |
| Avg. Estimate | 619.34M | 624.99M | 2.52B | 2.57B |
| Low Estimate | 609M | 605.75M | 2.49B | 2.45B |
| High Estimate | 626.77M | 639M | 2.56B | 2.71B |
| Year Ago Sales | 646.13M | 642.44M | 2.57B | 2.52B |
| Sales Growth (year/est) | -4.15% | -2.72% | -1.89% | 1.82% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| TDOC.MX | -- | -- | -- | -- |
| S&P 500 | 6.52% | 6.29% | 9.55% | 14.25% |
Upgrades & Downgrades
| Maintains | Goldman Sachs: Buy to Buy | 3/3/2025 |
| Reiterates | Needham: Hold to Hold | 2/27/2025 |
| Maintains | Piper Sandler: Overweight to Overweight | 2/27/2025 |
| Maintains | Goldman Sachs: Buy to Buy | 2/18/2025 |
| Maintains | B of A Securities: Neutral to Neutral | 2/12/2025 |
| Maintains | B of A Securities: Neutral to Neutral | 2/6/2025 |